[1]OPPENHEIMER AP, KOH C, McLAUGHLIN M, et al.Vanishing bile duct syndrome in human immunodeficiency virus infected adults:a report of two cases[J].World J Gastroenterol, 2013, 19 (1) :115-121.
|
[2]BHAYANA H, APPASANI S, THAPA BR, et al.Lamotrigineinduced vanishing bile duct syndrome in a child[J].J Pediatr Gastroenterol Nutr, 2012, 55 (6) :e147-e148.
|
[3]KAHN E.Biliary atresia revisite[J].Pediatr Dev Pathol, 2004, 7 (2) :109-124.
|
[4]HUMAR A, WASHBURN K, FREEMAN R, et al.An assessment of interactions between hepatitis C virus and herpesvirus reactivation in liver transplant recipientsusing molecular surveillance[J].Liver Transpl, 2007, 13 (10) :1422-1427.
|
[5]ARTHURS SK, EID AJ, PEDERSEN RA, et al.Delayed-onset primary cytomegalovirus disease after liver transplantation[J].Liver Transpl, 2007, 13 (12) :1703-1709.
|
[6]DESMET VJ.Vanishing bile duct syndrome in drug-induced liver disease[J].J Hepatol, 1997, 26 (Suppl 1) :31-35.
|
[7]PAUMGARTNER G, BEUERS U.Ursodeoxycholic acid in cholest atic liver disease:mechanisms of act ion and therapeutic use revisited[J].Hepatology, 2002, 36 (3) :525-531.
|
[8]NAKANUMA Y, TSUNEYAMA K, HARADA K.Pathology and pathogenesis of intrahepatic bile duct loss[J].J Hepatobiliary Pancreat Surg, 2001, 8 (4) :303-315.
|
[9]GEUBEL AP, SEMPOUX CL.Drug and toxin-induced bile duct disorders[J].J Gastroenterol Hepatol, 2000, 15 (11) :1232-1238.
|